Cost effectiveness analysis in health care: contraindications

被引:68
|
作者
Donaldson, C [1 ]
Currie, G
Mitton, C
机构
[1] Univ Newcastle Upon Tyne, Sch Populat & Hlth Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Business, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB 52N 4N1, Canada
[4] Univ Calgary, Dept Econ, Calgary, AB 52N 4N1, Canada
[5] Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB T2N 1N4, Canada
来源
BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7369期
关键词
D O I
10.1136/bmj.325.7369.891
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In economic evaluation of healthcare interventions, the dominant practice is to calculate an incremental cost effectiveness ratio, usually based on the comparison of a new intervention against current practice. Canadian and UK health economists question the economic foundations of such an approach.
引用
收藏
页码:891 / 894
页数:4
相关论文
共 50 条